Craig Lipset
@craiglipset.bsky.social
A guy and his dog modernizing clinical trials to serve patients. Board member, educator, advisor. Find me on Threads, X and Bluesky at @craiglipset
Despite post-JPM enthusiasm, there remains no clear industry-driven model to develop and deliver treatment options for those with the most rare of conditions.
January 19, 2025 at 3:38 PM
Despite post-JPM enthusiasm, there remains no clear industry-driven model to develop and deliver treatment options for those with the most rare of conditions.
